Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;3(4):199-206.
doi: 10.3978/j.issn.2304-3881.2014.06.02.

Are hematopoietic stem cells involved in hepatocarcinogenesis?

Affiliations
Review

Are hematopoietic stem cells involved in hepatocarcinogenesis?

Antonio Facciorusso et al. Hepatobiliary Surg Nutr. 2014 Aug.

Abstract

THE LIVER HAS THREE CELL LINEAGES ABLE TO PROLIFERATE AFTER A HEPATIC INJURY: the mature hepatocyte, the ductular "bipolar" progenitor cell termed "oval cell" and the putative periductular stem cell. Hepatocytes can only produce other hepatocytes whereas ductular progenitor cells are considerate bipolar since they can give rise to biliary cells or hepatocytes. Periductular stem cells are rare in the liver, have a very long proliferation potential and may be multipotent, being this aspect still under investigation. They originate in the bone marrow since their progeny express genetic markers of donor hematopoietic cells after bone marrow transplantation. Since the liver is the hematopoietic organ of the fetus, it is possible that hematopoietic stem cells may reside in the liver of the adult. This assumption is proved by the finding that oval cells express hematopoietic markers like CD34, CD45, CD 109, Thy-1, c-kit, and others, which are also expressed by bone marrow-derived hematopoietic stem cells (BMSCs). Few and discordant studies have evaluated the role of BMSC in hepatocarcinogenesis so far and further studies in vitro and in vivo are warranted in order to definitively clarify such an issue.

Keywords: Hepatocellular carcinoma (HCC); carcinogenesis; hematopoietic; stem cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Physiology of stem cells and their differentiation.

References

    1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118-27 - PubMed
    1. Lee AS, Tang C, Rao MS, et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 2013;19:998-1004 - PMC - PubMed
    1. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11 - PubMed
    1. Diehl AM. Neighborhood watch orchestrates liver regeneration. Nat Med 2012;18:497-9 - PubMed
    1. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006;66:4553-7 - PubMed